Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Invest Like a Machine!

Zacks Investment Research, Inc., www.zacks.com. (PRNewsFoto/Zacks Investment Research) (PRNewsFoto/ZACKS INVESTMENT RESEARCH)

News provided by

Zacks Investment Research, Inc.

Sep 21, 2012, 09:30 ET

Share this article

Share toX

Share this article

Share toX

CHICAGO, Sept. 21, 2012 /PRNewswire/ -- Zacks Investment Research presents their newest list of stocks featured in their weekly Research Wizard article, which describes how to profit from stock market opportunities.  The ideas in this article focus on using quantitative screens to select stocks.  Stocks include:  Ecopetrol S.A. (EC), AstraZeneca PLC (AZN), Reynolds American Inc. (RAI), Rentech Nitrogen Partners, L.P. (RNF) and H&R Block, Inc. (HRB).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Learn more about Research Wizard at this site: Research Wizard

Here are highlights from our most recent Research Wizard feature:

Last week, the Chicago Quantitative Alliance (CQA) held its annual fall conference.  As a member, I was able to attend this interesting two-day event.  The presentation I enjoyed the most was a psychology-based talk centered around the reasons why we don't perform our best and how to move toward optimal performance.  It reminded me of a book I recently finished titled The Inner Game of Tennis.  It's one of those books that have applications that reach much further than the title suggests.  So it could have easily been called The Inner Game of Preparing for Surgery, Stock Investing or Anything Else in Life.

The basic premise of these psychological performance themes is that we tend to over-think what we're doing and would be better off simply doing.  That is, of course, doing only after we've spent hours preparing or practicing to hone our game.  Once you are skilled at doing something, just do it.  Don't over-think.  Over-analysis can cause paralysis.  Certain thought processes during analysis could also lead to confirmation bias.  Studies have shown that both over-analysis and confirmation bias do impede performance.

While it's highly important to do your due diligence on stocks, I do believe too many investors buy into the story and become emotionally tied or mentally committed to a stock.  It's fairly clear that one should sell if conditions change and that's harder to do if you're committed to a stock.  You've got to be able to let go of a stock that's struggling or avoid it to begin with if something just isn't right. 

People also make the mistake of forming initial viewpoints and then only "see" things that confirm their first opinion and ignore items that don't match that preliminary thought.  This confirmation bias affects us in all aspects of life, including stock investing.  If you bought a stock, you clearly have a favorable viewpoint and will tend to ignore negative aspects that should be heeded. 

Avoid Potential Mistakes

That's why I take pleasure in investing in quantitative strategies.  After I've built a strategy that I am confident has a good economic rationale and superior performance, I follow it even if it tells me to sell a stock that I'd rather hold onto.  I remove emotion from the process and allow the strategy to drive returns by indicating when to buy and sell.  I also feel that's one thing that gives me an edge in the market.  I don't buy a "story" and am not committed to any specific stock.  I simply see them as interchangeable vehicles useful for making money.  I believe there are times when investors miss out on profitable opportunities because they're tied to a "story" stock whose price remains stagnant versus buying stocks with true return potential.  Remember, a good company is not always a good investment.

Also, I don't mind if a strategy tells me to short a well-known company or buy a company I've never heard of before.  So quantitative strategies also help remove familiarity bias, which is when one purchases only stocks he of she has heard of and avoids ones that are unfamiliar.  In fact, one of the things I like best about quantitative strategies is that they often unearth unfamiliar stocks.  These little-known stocks might provide great opportunities for profits because fewer eyes are watching them.

How To Just Do It

One of the easiest ways to implement a quantitative strategy is though a screen.  A screen is a great way to find stocks based on indicators that matter.  There is so much information available to investors that it's best to focus your stock picking on proven ideas.   

The Zacks Research Wizard allows one to shift through hundreds of different data items to determine which are the most important, and then develop a screen that will identify stocks that meet the desired criteria.  Once the screen has been tested to determine profitability, just save it and run it as often as you like to generate your list of stocks.

Since the Research Wizard contains a number of pre-built strategies, we'll take a look at Growth and Income Winners as an example.  Here's how that strategy compared to the S&P 500 on a historical test from August 2002- August 2012.


Ttl Rtn            

Invest $10K   

Ann. Rate       

Max Loss

Growth & Income Winners   

602.4%

$70,236

21.3%

-27.0%

S&P 500                                    

85.1%

$18,512

6.3%

-48.8%

Those results show that over time, the strategy significantly outperformed the S&P 500 over the last ten years.  Growth & Income Winners annualized rate of return was 15% higher with a maximum loss of about half as much as the S&P 500.  Now that's impressive!

Here's how to find Growth & Income Winners:

  • First, create a liquid, investible set of the stocks whose price is greater than $5 and average daily trading volume ≥ to 100,000 shares (if there's not enough liquidity, it'll be hard for you to trade).
  • Select only those stocks with a current Zacks Rank less than or equal to 3.  (You want stocks rated at least a buy or hold.)
  • Select companies with an ROE higher than the S&P 500 median.  (You want higher than average profitability.)
  • Next, pick those stocks with a P/E less than the S&P 500 median.  (You don't want to overpay for a stock.)
  • Then, choose only those with a Debt/Equity Ratio less than 1.  (Some debt is good.  Too much is a problem.)
  • Beta should be less than or equal to 1.00.  (Low volatility stocks reduce risk.)
  • Finally, select the 2 stocks in each sector with the highest Dividend Yield.  (You should be looking for a good dividend as well.)

Here are five of the ten stocks that passed the screen this week (9/21/12). 

EC – Ecopetrol S.A.

Ecopetrol, based in Bogota, Colombia, is an integrated oil company which engages in the exploration, development, and production of crude oil and natural gas.  This company has a better than average valuation (P/E of 13), good profitability (ROE of 32%) and has a 5.9% dividend yield.  Ecopetrol also has manageable debt levels (Debt/Equity of 20%) and a low volatility in its stock price.

AZN – AstraZeneca PLC

AstraZeneca engages in the discovery, development, and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory, inflammation, oncology, and infectious diseases worldwide.  This company, which is one of the top pharmaceutical companies in the world, has a very attractive valuation based on a P/E of 7.  This company also has good profitability measures and a lower than average debt level.  The dividend yield of 6.1% is also very appealing. 

RAI – Reynolds American Inc.

Reynolds American, through its subsidiaries, manufactures and sells cigarette and other tobacco products in the United States.  This company has a mildly attractive valuation, but is highly stable and profitable and offers a nice dividend for the price.  What I also like about this company is that they beat earnings expectations in the most recent quarter which leads to its Buy rating on the Zacks Rank.

RNF – Rentech Nitrogen Partners, L.P.

Rentech engages in the production of natural gas-based nitrogen fertilizer and industrial products for agricultural uses.  This highly profitable company, which is one you've probably never heard of, pays a nice dividend and its stock price is up 124% YTD.  Even considering the price appreciation, its P/E is still below the S&P 500's.  Earnings projections for the company have been revised upward many times leading to its Zacks Rank #1 rating.

HRB– H&R Block, Inc.

H&R Block, through its subsidiaries, engages in the provision of tax preparation and related services to the general public in the United States.  It's interesting that this stock passed the screen this week because it was mentioned at the CQA conference as a stock that would perform better with a Democrat in the Oval Office.  H&R Block's valuation is just a little better than average, but has a strong ROE (38%), high dividend yield (4.8%) and low debt.  It has also seen earnings projections for the next couple of years improve--perhaps in anticipation of an incumbent victory in November. 

Buy Results, Not a Story

Since not all analysis is good, you obviously need to focus on avoiding the bad analysis and concentrate on the good.  One of the easiest ways to do that is to implement a quantitative screen.  Once you have developed a screen that works; follow it!  It's good to confirm the numbers and ensure everything makes sense, but don't over-think the picks and get committed to a specific stock.  Get committed to the strategy and the complete portfolio!

The strategy highlighted in this article picks stocks that have low volatility and pay a high dividend.  These are also perfect stocks for a retracting market because there's usually a flight to quality and stability when the market's having an identity crisis.  Want to see other picks in the same genre?  Or perhaps you have other ideas on how to pick winning stocks?  No problem.  The Zacks Research Wizard can be used to develop a screen to uncover outperforming stocks for any investing style.

Starting today, you are invited to use it free of charge. You'll have 14 days to create, tweak, and backtest your strategies. At the same time, you can see the latest picks from pre-loaded winning strategies with average gains of up to +67.4% per year.

Learn more about your Research Wizard free trial >>

Let's make some money!

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks' portfolios and strategies are available at: http://www.zacks.com/performance.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:

Mark Vickery

Web Content Editor

312-265-9380

Visit: www.zacks.com

SOURCE Zacks Investment Research, Inc.

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.